CooperCompanies to Participate in the Oppenheimer Annual Healthcare Conference
February 18 2021 - 3:15PM
CooperCompanies (NYSE: COO), will participate in the Oppenheimer
31st Annual Healthcare Conference on Wednesday, March 17, 2021.
Daniel McBride, Esq, Executive Vice President, Chief Operating
Officer & President of CooperVision, will represent the Company
in a virtual session scheduled to begin at 1:10PM ET.
A live webcast of the Company’s session will be available on the
Investor Relations section of CooperCompanies’ website at
http://investor.coopercos.com. An archived audio file will be
available for replay on the same webpage later in the day.
About CooperCompaniesCooperCompanies ("Cooper")
is a global medical device company publicly traded on the NYSE
(NYSE:COO). Cooper operates through two business units,
CooperVision and CooperSurgical. CooperVision brings a refreshing
perspective on vision care with a commitment to developing a wide
range of high-quality products for contact lens wearers and
providing focused practitioner support. CooperSurgical is committed
to advancing the health of women, babies and families with its
diversified portfolio of products and services focusing on medical
devices and fertility & genomics. Headquartered in San Ramon,
CA, Cooper has a workforce of more than 12,000 with products sold
in over 100 countries. For more information, please visit
www.coopercos.com.
Contact:Kim DuncanVice President, Investor Relations and Risk
Management925-460-3663ir@cooperco.com
Cooper Companies (NYSE:COO)
Historical Stock Chart
From Apr 2024 to May 2024
Cooper Companies (NYSE:COO)
Historical Stock Chart
From May 2023 to May 2024